Literature DB >> 9119488

Characterization of two distinct opsonic and protective epitopes within the alpha C protein of the group B Streptococcus.

D E Kling1, C Gravekamp, L C Madoff, J L Michel.   

Abstract

Group B Streptococcus (GBS) is a major cause of neonatal sepsis, meningitis in early infancy, postpartum endometritis, and serious invasive infections in adults in the United States. We previously cloned, sequenced, and characterized the alpha antigen gene, bca, and showed that the alpha C protein of GBS is a trypsin-resistant, surface-associated polypeptide that contains a signal sequence, a unique N terminus, nine identical tandem repeats, and a C-terminal membrane anchor structure. Polyclonal antiserum raised to the recombinant alpha C protein and an opsonic monoclonal antibody, 4G8, raised to the native protein from GBS have been shown to be protective in a mouse model. The binding site of 4G8 has now been localized to the tandem repeat region of the alpha C protein. To determine whether the N terminus of the alpha C protein contains additional opsonic and/or protective epitopes, the sequence corresponding to the alpha C protein N terminus was subcloned into a pET vector, the expressed peptide from Escherichia coli was purified by Ni2+ affinity chromatography, and rabbit polyclonal antibodies were raised to the purified recombinant peptide. Antibodies to the alpha C protein N terminus were shown to be opsonic by an in vitro opsonophagocytosis assay. In addition, 69% of newborn mouse pups from mothers passively immunized with the antiserum to the recombinant N-terminal polypeptide of the alpha C protein were protected against lethal challenge with GBS A909. These data indicate that at least two distinct regions of the alpha C protein, the N terminus and the tandem repeat region, contain opsonic and protective epitopes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119488      PMCID: PMC175154          DOI: 10.1128/iai.65.4.1462-1467.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity.

Authors:  L O Hedén; E Frithz; G Lindahl
Journal:  Eur J Immunol       Date:  1991-06       Impact factor: 5.532

2.  The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions.

Authors:  P G Jerlström; G S Chhatwal; K N Timmis
Journal:  Mol Microbiol       Date:  1991-04       Impact factor: 3.501

Review 3.  Group A streptococcal antigens and vaccine potential.

Authors:  M A Kehoe
Journal:  Vaccine       Date:  1991-11       Impact factor: 3.641

4.  A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein.

Authors:  C S Lachenauer; L C Madoff
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.

Authors:  J L Michel; L C Madoff; D E Kling; D L Kasper; F M Ausubel
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

6.  Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.

Authors:  R S Baltimore; D L Kasper; C J Baker; D K Goroff
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

7.  ompT encodes the Escherichia coli outer membrane protease that cleaves T7 RNA polymerase during purification.

Authors:  J Grodberg; J J Dunn
Journal:  J Bacteriol       Date:  1988-03       Impact factor: 3.490

8.  Phenotypic diversity in the alpha C protein of group B streptococci.

Authors:  L C Madoff; S Hori; J L Michel; C J Baker; D L Kasper
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

9.  Neonatal mouse model of group B streptococcal infection.

Authors:  A K Rodewald; A B Onderdonk; H B Warren; D L Kasper
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

10.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  16 in total

1.  Tandem repeat deletion in the alpha C protein of group B streptococcus is recA independent.

Authors:  K M Puopolo; S K Hollingshead; V J Carey; L C Madoff
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Authors:  Ravin Seepersaud; Sean B Hanniffy; Peter Mayne; Phil Sizer; Richard Le Page; Jerry M Wells
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.

Authors:  B R Brodeur; M Boyer; I Charlebois; J Hamel; F Couture; C R Rioux; D Martin
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes.

Authors:  Augusta I Kvam; Rooyen T Mavenyengwa; Andreas Radtke; Johan A Maeland
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

Review 5.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

6.  Antibodies against Streptococcus agalactiae proteins c(alpha) and R4 in sera from pregnant women from Norway and Zimbabwe.

Authors:  S R Moyo; J A Maeland; J Mudzori
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

Review 7.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

8.  Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus.

Authors:  J Li; D L Kasper; F M Ausubel; B Rosner; J L Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

9.  Immunogenicity and protective efficacy of the alpha C protein of group B streptococci are inversely related to the number of repeats.

Authors:  C Gravekamp; D L Kasper; J L Michel; D E Kling; V Carey; L C Madoff
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

10.  Mass spectrometric analysis of Ehrlichia chaffeensis tandem repeat proteins reveals evidence of phosphorylation and absence of glycosylation.

Authors:  Abdul Wakeel; Xiaofeng Zhang; Jere W McBride
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.